Antitumor antisense oligonucleotides
AssigneeNovartis AG
InventorsHelmut Mett, Robert Haner, Nicholas Mark Dean
Life of this patent
Estimating the term…
Abstract
The invention relates to deoxyribo- and ribo-oligonucleotides and derivatives thereof, as well as pharmaceutical preparations, therapies, diagnostics and commercial research reagents in relation to disease states which respond to modulation of the synthesis of the enzyme S-adenosylmethionine decarboxylase (SAMDC). In particular, the invention relates to antisense oligonucleotides and oligonucleotide derivatives specifically hybridizable with nucleic acids relating to (preferably human) SAMDC. These oligonucleotides and their derivatives have been found to modulate the synthesis of SAMDC in cells.
Claims2
An oligonucleotide derivative consisting of a sequence of nucleotides and nucleotide analogues corresponding to a sequence selected from the group consisting of SEQ. ID. NO. 9 and SEQ. ID. NO. 10, said oligonucleotide derivative being complementary to the corresponding sequence of a mRNA deriving from the gene of human SAMDC, said oligonucleotide derivative modulating the biosynthesis of human SAMDC, or a salt of said oligonucleotide derivative where salt-forming groups are present.
Dependencies are inferred from the claim text.